Acalabrutinib Maleate
Intermediates
- Acalabrutinib maleate is a selective Bruton's tyrosine kinase (BTK) inhibitor used to treat mantle cell lymphoma and chronic lymphocytic leukemia by blocking B-cell receptor signaling. Reference standards of Acalabrutinib Maleate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Acalabrutinib Maleate
[catalogue_number] => PA 01 4320000
[category_ids] => ,70,78,82,
[chemical_name] =>
[weight] => 581.59
[form] => C30H27N7O6
[cas] => 2242394-65-4
[pslug] => 2242394-65-4-acalabrutinib-maleate-pa014320000
[latest_product] => 0
[linkproducts] => 1
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 01 4320000
Molecular Formula : C30H27N7O6
Molecular Weight : 581.59
stdClass Object
(
[pname] => Acalabrutinib Maleate (Amorphous Form)
[catalogue_number] => PA 01 4321000
[category_ids] => ,70,78,82,
[chemical_name] =>
[weight] => 581.59
[form] => C30H27N7O6
[cas] => 2514666-07-8 (Amorphous Form)
[pslug] => 2514666-07-8-acalabrutinib-maleate-amorphous-form-pa014321000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Acalabrutinib Maleate (Amorphous Form)
Catalogue No.:PA 01 4321000
CAS :
2514666-07-8 (Amorphous Form)
Molecular Formula : C30H27N7O6
Molecular Weight : 581.59
